Yahoo Finance1 个月
PepGen Announces Clinical Hold in the U.S. on IND Application to Initiate CONNECT2-EDO51 ...
Company continues to advance PGN-EDO51 in CONNECT1-EDO51, with the 10 mg/kg cohort now fully enrolled- BOSTON, December 16, 2024--(BUSINESS WIRE)--PepGen Inc. (Nasdaq: PEPG), a clinical-stage ...